Cite
HARVARD Citation
Ripabelli, G. et al. (2022). Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5–11 years: Results from an active pharmacovigilance study in central Italy. Human vaccines & immunotherapeutics. 18 (6), p. . [Online].